COQ7

Chr 16AR

coenzyme Q7, hydroxylase

Also known as: CAT5, COQ10D8, HMNR9

This gene encodes a mitochondrial hydroxylase that catalyzes a key step in coenzyme Q10 (ubiquinone) biosynthesis and helps stabilize the COQ enzyme complex. Autosomal recessive mutations cause primary coenzyme Q10 deficiency type 8 and distal hereditary motor neuronopathy type 9, affecting mitochondrial function and peripheral motor neurons. The gene is highly intolerant to loss-of-function variants (pLI near 1.0), suggesting complete loss of function may be embryonic lethal, while hypomorphic variants likely underlie the observed recessive phenotypes.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 1.492 OMIM phenotypes
Clinical SummaryCOQ7
🧬
Gene-Disease Validity (ClinGen)
distal hereditary motor neuropathy · ARStrong

Strong evidence — appropriate for clinical testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
26 unique Pathogenic / Likely Pathogenic· 118 VUS of 276 total submissions
📖
GeneReview available — COQ7
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.49LOEUF
pLI 0.000
Z-score 0.42
OE 0.86 (0.521.49)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.46Z-score
OE missense 1.11 (0.971.27)
153 obs / 137.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.86 (0.521.49)
00.351.4
Missense OE1.11 (0.971.27)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 9 / 10.5Missense obs/exp: 153 / 137.7Syn Z: -0.28
DN
0.7325th %ile
GOF
0.6639th %ile
LOF
0.2969th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

276 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic4
VUS118
Likely Benign93
Benign21
Conflicting10
22
Pathogenic
4
Likely Pathogenic
118
VUS
93
Likely Benign
21
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
6
14
0
22
Likely Pathogenic
3
1
0
0
4
VUS
11
88
18
1
118
Likely Benign
1
4
48
40
93
Benign
0
4
15
2
21
Conflicting
10
Total171039543268

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

COQ7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC